Asia Pacific Ambulatory Surgical Centers Market - 2024-2031

Report Overview

The Asia Pacific ambulatory surgical centers market reached US$ 18,500 million in 2023 and is expected to reach US$ 30,492 million by 2031, growing at a CAGR of 6.6% during the forecast period 2024-2031.

Ambulatory surgical centers (ASCs) are specialized healthcare facilities that offer outpatient surgical services so that patients can get treatments done without needing to stay overnight in the hospital. These facilities specialize in carrying out a wide range of surgical procedures, including gastrointestinal treatments as well as orthopedic and ophthalmology surgery. Because they provide more individualized patient care, shorter wait times, and costs that are frequently 20% to 50% less than in typical hospital settings, ASCs are gaining popularity these days.

Patients gain from a more comfortable environment and a more efficient procedure, which usually leads to quicker recovery periods and lower infection rates.

The ASC operational model places a strong emphasis on specialization and efficiency because their staff members are highly qualified professionals committed to providing outpatient care.

Market Dynamics: Drivers

Increasing prevalence of chronic diseases

The rising prevalence of chronic diseases propels the market growth. For instance, according to the National Institute of Health, noncommunicable diseases commonly include cardiovascular disease (CVD), various cancers, chronic respiratory illnesses, diabetes, and so on which are estimated to account for around 60% of all deaths. CVDs such as ischaemic heart disease and cerebrovascular such as stroke account for 17.7 million deaths and are the leading cause.

In accordance with the World Health Organization, India accounts for one-fifth of these deaths worldwide especially in younger population. The results of the Global Burden of Disease study state an age-standardized CVD death rate of 272 per 100000 population in India which is much higher than the global average of 235. CVDs strike Indians a decade earlier than the Western population.

In Indians, one of every ten persons aged 18 years has an increased blood glucose level. There were more than 73 million cases of diabetes in India in 2017 which is the highest in any country across the globe. Diabetes has become a challenge in India with a prevalence of 8.8% in the age group of 20 and 70 years. The rising prevalence of diabetes and other noncommunicable diseases has been linked to rapid urbanization, and globalization coupled with increasing sedentary lifestyles, unhealthy diets, overweight and obesity, tobacco use, and increasing life expectancy.

Restraints

Factors such as high costs of infrastructure and deployment are expected to hamper the market. For many healthcare providers, setting up and sustaining an ASC can be too costly both initially and over time. Significant recurring expenditures are associated with operating an ASC, including pay for IT workers who oversee the facility, maintenance, and repair charges, and electricity bills for cooling systems and servers.

Market Segment Analysis

The Asia Pacific ambulatory surgical centers market is segmented based on type, specialty, service, application, and end-user.

The segment hospital-based ASCs accounted for approximately 42.1% of the Asia Pacific ambulatory surgical centers market share.

The hospital-based ASCs segment is expected to hold the largest market share over the forecast period. In this segment, technological advancements would drive this market. Hospital-based ambulatory surgery centers are specialized establishments that offer outpatient surgical treatments, enabling patients to receive treatment without having to stay overnight in the hospital. Hospital-based ASCs function as distinct organizations with a focus on outpatient surgery even if they are integrated inside hospitals.

In response to the rising demand for same-day surgical treatments, they seek to offer a more effective and patient-centered approach to surgical care. Procedures at ASCs are usually less expensive than in conventional hospital settings. Because ASCs have lower overhead costs, patients can save anywhere from 20% to 50% on their surgery charges. Both patients and healthcare systems benefit from this financial efficiency.

Market Segmentation

By Type

Hospital-based ASCs

Free Standing ASCs

By Specialty

Single Specialty ASC

Multispecialty ASC

By Service

Diagnostics

Treatment

By Application

Gastroenterology

Ophthalmology

Orthopedics

Neurology

Dermatology

Urology

Others

By End-User

Hospitals

Specialty Clinics

Others

Market Competitive Landscape

The major players in the Asia Pacific ambulatory surgical centers market include SCA Health, Amsurg, HCA Management Services L.P, Fujifilm Holdings, Medtronic, Stryker, Koninklijke Philips N.V, Siemens Healthcare Private Limited, Boston Scientific Corporation, Johnson & Johnson Services Inc. among others.

Key Developments

In September 2023, Philips launched a new image-guided therapy mobile C-arm system called Zenition 30. The Zenition 30 system is equipped with advanced imaging AI algorithms that offer surgeons greater flexibility, control, and personalization in C-arm operation and image acquisition and reduce dependency on technician support for a wide variety of minimally invasive procedures.,

Why Purchase the Report?

To visualize the Asia Pacific ambulatory surgical centers market segmentation based on type, specialty, service, application, and end-user as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development

Excel data sheet with numerous data points of Asia Pacific ambulatory surgical centers market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in Excel consisting of key products of all the major players.

The Asia Pacific ambulatory surgical centers market report would provide approximately 51 tables, 54 figures, and 181 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies